{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:42:02Z","timestamp":1786992122281,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Electrocardiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jelectrocard.2024.05.083","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T02:16:31Z","timestamp":1716516991000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Electrocardiographic alterations in chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"85","author":[{"given":"Daniele","family":"Valente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Segreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihail","family":"Celeski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajana","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Vicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Gioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Paolo","family":"Ussia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Antonelli-Incalzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grigioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jelectrocard.2024.05.083_bb0005","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.mayocp.2018.05.026","article-title":"COPD guidelines: a review of the 2018 GOLD report","volume":"93","author":"Mirza","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0010","series-title":"Chronic obstructive pulmonary disease (COPD)","author":"WHO","year":"2023"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0015","doi-asserted-by":"crossref","DOI":"10.1007\/s40291-014-0100-9","article-title":"Defining phenotypes in COPD: an aid to personalized healthcare","author":"Segreti","year":"2014","journal-title":"Mol Diagn Ther"},{"issue":"149","key":"10.1016\/j.jelectrocard.2024.05.083_bb0020","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2018","article-title":"Cardiovascular disease and COPD: dangerous liaisons?","volume":"27","author":"Rabe","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"26","key":"10.1016\/j.jelectrocard.2024.05.083_bb0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.15585\/mmwr.mm7226a2","article-title":"Prevalence of adverse childhood experiences among U.S. adults - behavioral risk factor surveillance system, 2011-2020","volume":"72","author":"Swedo","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.jelectrocard.2024.05.083_bb0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2165\/00002512-200825090-00001","article-title":"What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?","volume":"25","author":"Bhatt","year":"2008","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.jelectrocard.2024.05.083_bb0035","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.rmed.2011.01.008","article-title":"Lower limit of normal or FEV1\/FVC < 0.70 in diagnosing COPD: an evidence-based review","volume":"105","author":"Mohamed Hoesein","year":"2011","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.jelectrocard.2024.05.083_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-2600(15)00518-4","article-title":"Cardiac effects of current treatments of chronic obstructive pulmonary disease","volume":"4","author":"Lahousse","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"19","key":"10.1016\/j.jelectrocard.2024.05.083_bb0045","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/heartjnl-2016-310897","article-title":"Cardiovascular outcomes with an inhaled beta2-agonist\/corticosteroid in patients with COPD at high cardiovascular risk","volume":"103","author":"Brook","year":"2017","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.jelectrocard.2024.05.083_bb0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S2213-2600(21)00506-3","article-title":"Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment","volume":"10","author":"Yang Ian","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.jelectrocard.2024.05.083_bb0055","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1038\/s41598-023-39001-z","article-title":"Examining changes in vascular function, arterial stiffness, and systemic inflammation during hospitalization and recovery from an acute exacerbation of chronic obstructive pulmonary disease","volume":"13","author":"Fuhr","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0060","doi-asserted-by":"crossref","DOI":"10.1177\/1753465817750524","article-title":"Defining the relationship between COPD and CVD: what are the implications for clinical practice?","volume":"12","author":"Morgan","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0065","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/COPD.S49621","article-title":"Epidemiology and clinical impact of major comorbidities in patients with COPD","volume":"9","author":"Smith","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0070","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.00012408","article-title":"Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD","volume":"32","author":"Mannino","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/COPD.S6400","article-title":"Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity","volume":"4","author":"Finkelstein","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.jelectrocard.2024.05.083_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa0808836","article-title":"Percent emphysema, airflow obstruction, and impaired left ventricular filling","volume":"362","author":"Barr","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jelectrocard.2024.05.083_bb0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.pupt.2006.02.002","article-title":"Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients","volume":"20","author":"Cazzola","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.resinv.2019.03.013","article-title":"Chronic obstructive pulmonary disease and the early stage of cor pulmonale: a perspective in treatment with pulmonary arterial hypertension-approved drugs","volume":"57","author":"Sakao","year":"2019","journal-title":"Respir Investig"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0095","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jelectrocard.2024.05.083_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1479972309104664","article-title":"Cor pulmonale","volume":"6","author":"Weitzenblum","year":"2009","journal-title":"Chron Respir Dis"},{"issue":"10","key":"10.1016\/j.jelectrocard.2024.05.083_bb0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4330\/wjc.v13.i10.533","article-title":"Electrocardiographic changes in emphysema","volume":"13","author":"Gupta","year":"2021","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0110","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.jelectrocard.2024.05.083_bb0115","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jaci.2018.02.035","article-title":"Chronic obstructive pulmonary disease subpopulations and phenotyping","volume":"141","author":"Segal","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1183\/09031936.05.00023704","article-title":"Correlation of lung surface area to apoptosis and proliferation in human emphysema","volume":"25","author":"Imai","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaci.2016.04.028","article-title":"Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome?","volume":"138","author":"Cazzola","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0130","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1183\/13993003.00436-2016","article-title":"What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion","volume":"48","author":"Sin","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0135","unstructured":"Oreto G. L\u2019elettrocardiogramma: un mosaico a 12 tessere. Edi-ermes 2010; Chapter 4 \"L'onda P e gli ingrandimenti atriali\". 2024. p. 39."},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-8703(48)90118-5","article-title":"Electrocardiogram in chronic cor pulmonale","volume":"35","author":"Zuckermann","year":"1948","journal-title":"Am Heart J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0145","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.amjcard.2010.11.039","article-title":"Electrocardiographic detection of emphysema","volume":"107","author":"Thomas","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/clc.4960220313","article-title":"Electrocardiographic screening for emphysema: the frontal plane P axis","volume":"22","author":"Baljepally","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0155","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0002-8703(70)90248-6","article-title":"P-wave changes in chronic obstructive pulmonary disease","volume":"79","author":"Calatayud","year":"1970","journal-title":"Am Heart J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12931-019-1025-y","article-title":"Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD","volume":"20","author":"Alter","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.63.2.146","article-title":"Correlations of electrocardiographic features with airway obstruction in chronic bronchitis","volume":"63","author":"Tandon","year":"1973","journal-title":"Chest"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-0736(85)80047-9","article-title":"P-wave changes in obstructive and restrictive lung diseases","volume":"18","author":"Ikeda","year":"1985","journal-title":"J Electrocardiol"},{"issue":"1","key":"10.1016\/j.jelectrocard.2024.05.083_bb0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.11622\/smedj.2020003","article-title":"ECG P wave abnormalities","volume":"54","author":"Tan","year":"2013","journal-title":"Singapore Med J"},{"issue":"12","key":"10.1016\/j.jelectrocard.2024.05.083_bb0180","article-title":"Electrocardiographic abnormalities in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"13","author":"Kumar","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.jelectrocard.2024.05.083_bb0185","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jelectrocard.2017.04.012","article-title":"Correlation of right atrial enlargement on ECG to right atrial volume by echocardiography in patients with pulmonary hypertension","volume":"50","author":"Allison","year":"2017","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0190","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0736-4679(90)90458-8","article-title":"The electrocardiogram in chronic obstructive pulmonary disease","volume":"8","author":"Rodman","year":"1990","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0195","first-page":"287","article-title":"Low amplitude P, QRS and T wave pattern in lead I\u2013the \u201cisoelectric lead I sign\u201d","volume":"39","author":"MacKenzie","year":"2007","journal-title":"J Insur Med"},{"issue":"1","key":"10.1016\/j.jelectrocard.2024.05.083_bb0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jelectrocard.2017.09.004","article-title":"Electrocardiographic recognition of right ventricular hypertrophy","volume":"51","author":"Nikus","year":"2018","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0205","series-title":"Pulmonary diseases and disorders","first-page":"471","article-title":"The electrocardiogram in pulmonary disease","author":"Holford","year":"1988"},{"issue":"12","key":"10.1016\/j.jelectrocard.2024.05.083_bb0210","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/01.CIR.99.12.1600","article-title":"Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease","volume":"99","author":"Incalzi","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hrtlng.2016.04.004","article-title":"Identification of electrocardiographic values that indicate chronic obstructive pulmonary disease","volume":"45","author":"Ichikawa","year":"2016","journal-title":"Heart Lung"},{"issue":"3","key":"10.1016\/j.jelectrocard.2024.05.083_bb0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0022-0736(91)90029-L","article-title":"Evaluation of the electrocardiographic transitional zone by cardiac computed tomography","volume":"24","author":"Tahara","year":"1991","journal-title":"J Electrocardiol"},{"issue":"3-4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2298\/MPNS1304126L","article-title":"Analysis of electrocardiogram in chronic obstructive pulmonary disease patients","volume":"LXVI","author":"Lazovic","year":"2013","journal-title":"Med Pregl"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0230","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2147\/COPD.S132538","article-title":"T wave peak-to-end interval in COPD","volume":"13","author":"Tural","year":"2018","journal-title":"Int J COPD"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/15412555.2012.727918","article-title":"Electrocardiographic characteristics of patients with chronic obstructive pulmonary disease","volume":"10","author":"Warnier","year":"2013","journal-title":"COPD"},{"issue":"5","key":"10.1016\/j.jelectrocard.2024.05.083_bb0240","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/eurheartj\/ehaa822","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective","volume":"42","author":"Simons","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0245","first-page":"2908","article-title":"Atrial fibrillation in the acute, hypercapnic exacerbations of COPD","volume":"18","author":"Terzano","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0250","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM196808152790703","article-title":"Multifocal atrial tachycardia: clinical and electrocardiographic features in 32 patients","volume":"279","author":"Shine","year":"1968","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jelectrocard.2024.05.083_bb0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1378\/chest.113.1.203","article-title":"Multifocal atrial tachycardia","volume":"113","author":"McCord","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/5584_2017_41","article-title":"Cardiac arrhythmias in patients with exacerbation of COPD","volume":"1022","author":"Rusinowicz","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0265","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacep.2015.06.005","article-title":"Chronic obstructive pulmonary disease and risk of sudden cardiac death","volume":"1","author":"Narayanan","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0270","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/eurheartj\/ehv121","article-title":"Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study","volume":"36","author":"Lahousse","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0275","article-title":"Cardiac arrhythmias and left ventricular function in respiratory failure from chronic obstructive pulmonary disease","volume":"91","author":"Lncalzi","year":"1990","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jelectrocard.2024.05.083_bb0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41533-021-00221-3","article-title":"Association between chronic obstructive pulmonary disease and ventricular arrhythmia: a nationwide population-based cohort study","volume":"31","author":"Chen","year":"2021","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0285","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1378\/chest.11-1597","article-title":"Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort","volume":"142","author":"Wilchesky","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0290","article-title":"Association of chronic obstructive pulmonary disease with arrhythmia risks: a systematic review and meta-analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.jelectrocard.2024.05.083_bb0295","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.93.06020204","article-title":"A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol","volume":"6","author":"Bremner","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2466-14-55","article-title":"High prevalence of altered cardiac repolarization in patients with COPD","volume":"14","author":"Sievi","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0305","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1378\/chest.122.6.2055","article-title":"Ventricular arrhythmias in patients with COPD arsimoe associated with QT dispersion","volume":"122","author":"Yildiz","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0310","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/COPD.S157630","article-title":"Significance of prolonged QTc in acute exacerbations of COPD requiring hospitalization","volume":"13","author":"Van Oekelen","year":"2018","journal-title":"Int J COPD"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0315","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000552","article-title":"Mechanisms of ECG signs in chronic obstructive pulmonary disease","volume":"4","author":"Larssen","year":"2017","journal-title":"Open Heart"},{"issue":"1","key":"10.1016\/j.jelectrocard.2024.05.083_bb0320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5578\/tt.4101","article-title":"The role of electrocardiography in evaluation of severity of chronic obstructive pulmonary disease in daily clinical practice","volume":"61","author":"Akturk","year":"2013","journal-title":"Tuberk Toraks"},{"issue":"4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0325","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00239-2023","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary","volume":"61","author":"Agust\u00ed","year":"2023","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jelectrocard.2024.05.083_bb0330","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jfda.2018.12.006","article-title":"Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease","volume":"27","author":"Wang","year":"2019","journal-title":"J Food Drug Anal"},{"issue":"4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0335","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1164\/ajrccm.164.4.2007085","article-title":"Marked sympathetic activation in patients with chronic respiratory failure","volume":"164","author":"Heindl","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1070327","article-title":"A systematic review and meta-analysis of heart rate variability in COPD","volume":"10","author":"Alqahtani","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0345","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1378\/chest.114.2.411","article-title":"Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia","volume":"114","author":"Cazzola","year":"1998","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jelectrocard.2024.05.083_bb0350","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.14-0117","article-title":"One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD","volume":"146","author":"Donohue","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0355","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1476-5381.1980.tb10868.x","article-title":"Beta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K transport in rat soleus muscle","volume":"68","author":"Clausen","year":"1980","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.jelectrocard.2024.05.083_bb0360","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00044011-199815060-00009","article-title":"Hypokalemia in healthy volunteers after single and multiple doses of formoterol or salbutamol","volume":"15","author":"van den Berg","year":"1998","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.jelectrocard.2024.05.083_bb0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1378\/chest.08-2367","article-title":"Cardiovascular events associated with ipratropium bromide in COPD","volume":"137","author":"Ogale","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2015.04.129","article-title":"Inhaled bronchodilators and the risk of tachyarrhythmias","volume":"190","author":"Lee","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.jelectrocard.2024.05.083_bb0375","first-page":"505","article-title":"Adverse effects of corticosteroids on the cardiovascular system","volume":"16","author":"Sholter","year":"2000","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.jelectrocard.2024.05.083_bb0380","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1183\/09031936.03.00027003","article-title":"Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease","volume":"22","author":"Calverley","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0385","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/00003495-200969050-00004","article-title":"Efficacy and tolerability of budesonide\/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial","volume":"69","author":"Rennard","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0390","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1378\/chest.80.6.661","article-title":"Cardiac arrhythmias due to oral aminophylline in patients with chronic obstructive pulmonary disease","volume":"80","author":"Patel","year":"1981","journal-title":"Chest"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0395","first-page":"322","article-title":"Theophylline-induced alterations in cardiac electrophysiology in patients with chronic obstructive pulmonary disease","volume":"135","author":"Eiriksson","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0400","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)62410-7","article-title":"Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicenter randomized controlled trial","volume":"385","author":"Martinez","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jelectrocard.2024.05.083_bb0405","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1715163516641136","article-title":"Drug-induced QT interval prolongation and torsades de pointes: role of the pharmacist in risk assessment, prevention and management","volume":"149","author":"Tisdale","year":"2016","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.jelectrocard.2024.05.083_bb0410","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2010.03660.x","article-title":"Drug- and non-drug-associated QT interval prolongation","volume":"70","author":"van Noord","year":"2010","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Electrocardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073624001456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073624001456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T07:54:33Z","timestamp":1723017273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022073624001456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":82,"alternative-id":["S0022073624001456"],"URL":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2024.05.083","relation":{},"ISSN":["0022-0736"],"issn-type":[{"value":"0022-0736","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrocardiographic alterations in chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Electrocardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2024.05.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}